These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Author: Royal College of General Practitioners Medicines Surveillance Organisation.
    Journal: J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412.
    Abstract:
    In a double-blind randomized trial, 120 patients suffering from acute anxiety states received treatment for two weeks with bromazepam 3 mg, bromazepam 6 mg or diazepam 5 mg, each given three times daily. A shortened Hamilton anxiety rating scale showed similar and significant improvement with all three regimens. However, a global rating scale showed that, in the physicians' opinion, the lower dose of bromazepam was preferred. Its use was associated with the lowest incidence of adverse reactions and best dosage compliance. A twice daily administration of bromazepam may offer further advantage, as may a lower unit dose.
    [Abstract] [Full Text] [Related] [New Search]